Figure 2.
Estimated cumulative risk (%) of ovarian cancer in a PALB2 deleterious variant carrier compared with population risks for England and Wales, 2016.
Estimated cumulative risk (%) of ovarian cancer in a PALB2 deleterious variant carrier compared with population risks for England and Wales, 2016.